Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Insulin Analog [EPC]: Side Effects & Safety Data for 6 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Insulin Analog [EPC] includes 6 drugs with a combined 226,217 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

6
Drugs in Class
226,217
Combined Reports

All Insulin Analog [EPC] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
INSULIN GLARGINE Lantus Solostar 99,509 2,311 13,970 2.3%
INSULIN LISPRO Humalog KwikPen 80,080 1,285 10,547 1.6%
INSULIN ASPART NovoLog Mix 70/30 22,014 1,350 7,879 6.1%
INSULIN DEGLUDEC TRESIBA 11,514 555 2,549 4.8%
INSULIN DETEMIR Levemir 9,651 373 2,723 3.9%
INSULIN GLULISINE Apidra 3,449 213 1,176 6.2%

Common Side Effects in Insulin Analog [EPC] Drugs

Side EffectReportsDeaths
Blood glucose increased 61,301 166
Blood glucose decreased 14,192 69
Drug ineffective 12,029 189
Incorrect dose administered 11,754 18
Visual impairment 11,591 23
Product storage error 9,698 16
Hypoglycaemia 9,597 305
Inappropriate schedule of product administration 9,538 59
Off label use 8,035 486
Glycosylated haemoglobin increased 6,448 39
View detailed side effects for this class → Compare drugs in this class →